ArticleFrontiers in medicine2026
Thrombus straddling the patent foramen ovale: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A transseptal thrombus straddling the patent foramen ovale (TSFO) is a rare but potentially life-threatening imaging finding that often serves as direct evidence of paradoxical embolism. Given its dynamic and transient nature, timely recognition is crucial to prevent systemic embolism. Case summary: We report an 81-year-old woman admitted for acute dyspnea. Transthoracic echocardiography (TTE) on admission revealed no intracardiac thrombus. However, contrast-enhanced cardiac computed tomography (CT) performed the following day unexpectedly demonstrated a linear hypodense lesion spanning the interatrial septum at the fossa ovalis, exhibiting the "straddling sign" and confirming the diagnosis of TSFO. Following shared decision-making with the patient, anticoagulation alone was deemed the optimal management. Telephone follow-ups at 1 and 3 months, and up to 2 years post-discharge, demonstrated a favorable clinical recovery. Discussion: This case highlights the diagnostic value of contrast-enhanced CT angiography in identifying TSFO in the setting of acute pulmonary embolism. Although TSFO is rare, it represents a "window period" manifestation of paradoxical embolism, necessitating heightened vigilance from both radiologists and clinicians. Early identification and initiation of anticoagulant therapy can effectively prevent systemic thromboembolic events and improve prognosis. Due to its dynamic and transient nature, imaging capture particularly on CT angiography is exceedingly rare. This case demonstrates a clear image of a transseptal thrombus, holding significant clinical and educational value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.